XML 32 R18.htm IDEA: XBRL DOCUMENT v3.24.3
(Gain) Loss from Divestitures, Asset Impairments and Unusual Items, Net
9 Months Ended
Sep. 30, 2024
(Gain) Loss from Divestitures, Asset Impairments and Unusual Items, Net  
(Gain) Loss from Divestitures, Asset Impairments and Unusual Items, Net

9.  (Gain) Loss from Divestitures, Asset Impairments and Unusual Items, Net

(Gain) loss from divestitures, asset impairments and unusual items, net for the three months ended September 30, 2024 primarily relates to a $14 million loss associated with the divestiture of a minority investment in a medical waste company within Corporate and Other, in connection with our pending acquisition of Stericycle. The nine months ended September 30, 2024 include a $54 million charge required to increase the estimated fair value of a liability associated with the expected disposition of an investment the Company holds in a waste diversion technology business recorded during the second quarter of 2024. This charge is reflected in our Corporate and Other measures within our segment reporting. (Gain) loss from divestitures, asset impairments and unusual items, net for the three and nine months ended September 30, 2023 were not material.